Follow The Filings

LQDA Liquidia Corporation

Health Care, filed as LIQUIDIA CORPORATION (COM NEW), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q3, sold by 1

  • 2 Owners
  • Max 7.2%
  • $333M
  • 1 add 1 reduce

In 2026 Q3 Farallon Capital Management added to Liquidia, while James Silverman trimmed.

Who owns this now

Largest portfolio weights among holders, up to 7.2% (James Silverman, Opaleye Management). Not free-float ownership.

  1. James Silverman Reduce 7.2%
  2. Farallon Capital Management Add 1.2%

Who owns LQDA

Sorted by value, long equity only, as of 2026 Q3.

History
Farallon Capital Management 1.2% Add +6.5% 8,906,038 $269M History
James Silverman, Opaleye Management 7.2%, was 17.7% Reduce −13.8% 2,110,000 $64M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by LQDA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All LQDA insider trades
  • $318K bought by 1 insider
  • $151M sold by 7 insiders outside a trading plan
  • $51.5M sold by 6 insiders under 10b5-1 plans
  1. Stephen M. Bloch Director
    Sale
    $6.4M 235,477 shares at $27.13 100% of stake
    Traded Oct 5 Filed Oct 7
  2. Raman Singh Director
    Sale
    $1.2M 17,492 shares at $67.43 28% of stake
    Traded Sep 11–14 Filed Sep 15
  3. Jason Adair Chief Business Officer
    Planned sale
    $5.1M 73,631 shares at $69.09 30% of stake
    Traded Aug 21 Filed Aug 25
  4. Katherine Rielly-Gauvin Director
    Planned sale
    $4.1M 55,182 shares at $74.07 55% of stake
    Traded Aug 19–20 Filed Aug 21
  5. Rajeev Saggar Chief Medical Officer
    Sale
    $6M 79,534 shares at $75.09 36% of stake
    Traded Aug 17–19 Filed Aug 19
  6. Stephen M. Bloch Director
    Sale
    $17.8M 200,000 shares at $88.93 29% of stake
    Traded Jul 22–23 Filed Jul 24
  7. Stephen M. Bloch Director
    Sale
    $6.3M 78,596 shares at $79.97 10% of stake
    Traded Jul 20–21 Filed Jul 22
  8. Stephen M. Bloch Director
    Sale
    $6.1M 75,000 shares at $80.68 8.8% of stake
    Traded Jul 6–7 Filed Jul 8
  9. Stephen M. Bloch Director
    Sale
    $2M 25,000 shares at $79.47 2.8% of stake
    Traded Jul 1 Filed Jul 6
  10. Stephen M. Bloch Director
    Sale
    $7.6M 100,000 shares at $75.74 10% of stake
    Traded Jun 22 Filed Jun 24
  11. Stephen M. Bloch Director
    Sale
    $14M 196,111 shares at $71.45 17% of stake
    Traded Jun 12–15 Filed Jun 16
  12. Sarah Krepp Chief Human Resource Officer
    Planned sale
    $1.7M 24,880 shares at $70.28 17% of stake
    Traded Jun 11 Filed Jun 15
  13. Stephen M. Bloch Director
    Sale
    $26.6M 388,223 shares at $68.61 25% of stake
    Traded Jun 10–11 Filed Jun 12
  14. Stephen M. Bloch Director
    Sale
    $14.3M 220,835 shares at $64.64 12% of stake
    Traded Jun 8–9 Filed Jun 10
  15. Paul B. Manning Director
    Sale
    $12.8M 200,000 shares at $63.91 20% of stake
    Traded Jun 4 Filed Jun 8

Also filed in the last 12 months, not counted as buying or selling: 96 option exercises, 66 sales to cover taxes, 19 stock grants, and 2 other transactions.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
SCHEDULE 13G —
8-K 5.02,9.01
10-Q
8-K 2.02,8.01,9.01
8-K 1.01,1.02,7.01,8.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
SCHEDULE 13G/A —
8-K 2.02,8.01,9.01
10-Q
SCHEDULE 13G/A —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $17.49M $14M $158.32M
Gross profit * $14.6M $8.12M —
Gross margin * 83.5% 58.0% —
Net income -$78.5M -$130.39M -$68.92M
Net margin * -448.9% -931.7% -43.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $89.9M $185.1M $273.4M
Total non-current assets * $28.43M $45.21M $54.53M
Total assets $118.33M $230.31M $327.93M
Total current liabilities $18.55M $41.78M $135.77M
Total non-current liabilities * $52.49M $111.26M $147.42M
Total equity $47.29M $77.28M $44.75M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$41.56M -$93.42M -$35.69M
Cash from investing -$11.29M -$8.44M -$6.34M
Cash from financing $43.25M $194.66M $59.73M
Net change in cash -$9.6M $92.8M $17.7M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf